Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Feb;41(2):153-162.
doi: 10.1007/s40618-017-0738-3. Epub 2017 Jul 28.

Non-surgical ablative therapies for inoperable benign insulinoma

Affiliations
Review

Non-surgical ablative therapies for inoperable benign insulinoma

C Mele et al. J Endocrinol Invest. 2018 Feb.

Abstract

Purpose: Benign insulinoma is the most common functioning neuroendocrine tumor of the pancreas. The gold-standard therapeutic approach for insulinoma is surgery, which allows for tumor removal, histology and immunochemical analyses. If surgery is not feasible, minimally invasive ablative procedures performed by interventional radiology can lead to partial or complete remission of hormone hypersecretion and tumor control in insulinoma patients.

Methods: We performed a review of existing literature on non-chemotherapeutic/radioactive ablative techniques employed for the treatment of benign, otherwise inoperable, pancreatic insulinoma. For this purpose, feasibility, effectiveness and safety of ablative treatments for pancreatic insulinoma were reviewed from literature data published from 1982 to date.

Results: A total of 44 insulinoma cases treated with non-surgical ablative techniques were desumed, and divided as follows: 7 cases of tumor embolization, 26 ethanol ablations, 7 radiofrequency ablations, 2 high intensity focused ultrasound ablation, 1 irreversible electroporation and 1 percutaneous microwave ablation. Most cases involved single insulinoma, predominantly located in the pancreas head and body. In the majority of patients, ablation was chosen instead of surgery due to severe comorbidities. After an average follow-up of 16 months, the overall success rate of non-surgical ablative treatments of insulinoma was 84%, the recurrence/persistence rate was 16%, and transient adverse events were noted in 23% of cases. Adverse events were usually self-limiting and medically manageable.

Conclusions: Non-surgical ablation is a feasible, safe and repeatable procedure in patients with pancreatic insulinoma, who are not candidate to surgery or refuse it. Partial or complete control of symptoms and tumor growth is experienced by the majority of patients.

Keywords: Ablation; Electroporation; Embolization; Ethanol; Insulinoma; Microwave; Radiofrequency; Ultrasound.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Gastrointest Endosc. 2016 Jan;83(1):234-9 - PubMed
    1. JAMA. 1982 Sep 17;248(11):1353-5 - PubMed
    1. Acta Gastroenterol Belg. 2008 Jul-Sep;71(3):333-7 - PubMed
    1. Curr Opin Oncol. 2008 Jan;20(1):25-33 - PubMed
    1. Gastrointest Endosc. 2012 Jan;75(1):200-6 - PubMed

LinkOut - more resources